{"id":"W2804131537","doi":"10.1111/bjd.16798","title":"Tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovaderm (Canada); Probity Medical Research","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Plaque psoriasis; Psoriasis; Open label; Dermatology; Term (time); Extension (predicate logic); Internal medicine; Adverse effect; Computer science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002338471,0.0002258141,0.0007520859,0.0002779994,0.0001761443,0.00006670159,0.0003694016,0.0002368455,0.00008709103],"category_scores_gemma":[0.00005067897,0.0002158616,0.00002279697,0.0002167603,0.0001412193,0.0004207603,0.0001552636,0.000316236,0.00002584722],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009405522,"about_ca_system_score_gemma":0.0001640401,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001064771,"about_ca_topic_score_gemma":0.004158133,"domain_scores_codex":[0.9977596,0.0006541376,0.0007107479,0.0003838925,0.0000650209,0.0004265472],"domain_scores_gemma":[0.9991366,0.00009351804,0.0002678279,0.0002061636,0.0002181948,0.00007774584],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01261326,0.005327946,0.8817191,0.0000134255,0.0002423239,0.00243268,0.0008508716,0.000009025273,0.0004816275,0.00001029712,0.0001289113,0.09617055],"study_design_scores_gemma":[0.05391414,0.00388604,0.9326661,0.0003305629,0.00008055886,0.008112288,0.0001129323,0.000002270512,0.0005840234,0.00001055329,0.00006069187,0.0002398653],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969109,0.001746525,0.00003007427,0.00009552632,0.0003645208,0.0007706535,0.00003744809,0.00001071459,0.00003364261],"genre_scores_gemma":[0.9994645,0.0001839009,0.00009873314,0.0001002967,0.00003564768,0.00001399278,0.00005283684,0.00002438996,0.00002577542],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09593068,"threshold_uncertainty_score":0.8802579,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01980656841918901,"score_gpt":0.2715393643910453,"score_spread":0.2517327959718563,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}